Status of work in December
In December, AOTMiT begins work on orders from the Minister of Health:
- Keytruda (pembrolizumab) for the treatment of patients with esophageal, gastroesophageal junction, and gastric cancer
- Mektovi (braftovi) for the treatment of patients with lung cancer and pleural mesothelioma
- Keytruda (pembrolizumab) for the treatment of patients with esophageal, gastroesophageal junction, and gastric cancer
The listed order is available on the AOTMiT Public Information Bulletin.